Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection

The Journal of Infectious Diseases
R J QuinnellMarie-Anne Shaw

Abstract

Cytokine and proliferative responses to Necator americanus infection were measured in a treatment-reinfection study of infected subjects from an area of Papua New Guinea where N. americanus is highly endemic. Before treatment, most subjects produced detectable interleukin (IL)-4 (97%), IL-5 (86%), and interferon (IFN)- gamma (64%) in response to adult N. americanus antigen. Pretreatment IFN- gamma responses were negatively associated with hookworm burden, decreasing by 18 pg/mL for each increase of 1000 eggs/gram (epg) (n=75; P<.01). Mean IFN- gamma responses increased significantly after anthelmintic treatment, from 166 to 322 pg/mL (n=42; P<.01). The intensity of reinfection was significantly negatively correlated with pretreatment IL-5 responses, decreasing by 551 epg for each 100 pg/mL increase in production of IL-5 (n=51; P<.01). These data indicate that there is a mixed cytokine response in necatoriasis, with worm burden-associated suppression of IFN- gamma responses to adult N. americanus antigen. Resistance to reinfection is associated with the parasite-specific IL-5 response.

Citations

Dec 29, 2005·Parasitology Research·Nancy MallaManzoor Ahmad Thokar
Mar 23, 2005·Trends in Parasitology·Franco H Falcone, David I Pritchard
Nov 20, 2004·Transactions of the Royal Society of Tropical Medicine and Hygiene·Adrienne E ShapiroSimon Brooker
Feb 6, 2007·Parasitology·J M BethonyD P Knox
Oct 22, 2008·Parasitology·L Ph BreitlingR J Quinnell
Aug 5, 2010·The Journal of Infectious Diseases·Rupert J QuinnellJeffrey M Bethony
Mar 12, 2008·Journal of the Royal Society, Interface·L SabatelliS Brooker
Oct 5, 2012·Clinical Microbiology Reviews·Henry J McSorley, Rick M Maizels
Mar 19, 2008·Infection and Immunity·Blaise DondjiMichael Cappello
Jun 17, 2006·American Journal of Respiratory and Critical Care Medicine·Jo Leonardi-BeeJohn Britton
Jun 5, 2008·PLoS Neglected Tropical Diseases·Amara E EzeamamaJennifer F Friedman
Apr 7, 2011·PLoS Neglected Tropical Diseases·Mushfiqur R TarafderRemigio Olveda
Jan 23, 2016·Experimental Parasitology·Marcin WiśniewskiHalina Wędrychowicz
Sep 10, 2010·The Science of the Total Environment·M BragaM Di Gioacchino
Oct 14, 2008·Microbes and Infection·Stefan M GeigerJeffrey M Bethony
Mar 18, 2005·Parasite Immunology·R J QuinnellD I Pritchard
Oct 20, 2005·Clinical and Experimental Immunology·V Wright, Q Bickle
Jun 20, 2007·Parasite Immunology·S M GeigerJ M Bethony
Jan 10, 2006·Tropical Medicine & International Health : TM & IH·Fiona M FlemingJeffrey M Bethony
Jul 18, 2006·Parasite Immunology·R T FujiwaraS Mendez
Aug 19, 2011·Alimentary Pharmacology & Therapeutics·J KabeerdossB S Ramakrishna
Oct 23, 2014·Parasite Immunology·S GazeM V Periago
Sep 10, 2014·Parasite Immunology·C ZaphN L Harris
Oct 13, 2006·Trends in Parasitology·John Croese, Richard Speare
Aug 8, 2006·Gastroenterology·John CroeseRichard Speare

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

© 2022 Meta ULC. All rights reserved